If you enjoy this content, please share it with a colleague
RELATED CONTENT
August 5, 2011 — Elekta has signed a definitive agreement to acquire Nucletron, a worldwide provider of technology for brachytherapy treatment planning and delivery.
Treatment planning is a critical component of a patient’s road toward an optimal outcome when dealing with cancer. Whether the ultimate goal is palliative or a total cure, treatment planning always aims to provide just enough dose to a targeted area to eradicate the cancer, while sparing nearby tissue or organs.
May 6, 2011 – Nucletron will feature five new innovations at the ESTRO Anniversary Congress, May 8-11 in London, all designed to meet the growing interest and need to more effectively treat a wide variety of cancers. In addition Nucletron will be celebrating its long collaboration with ESTRO on its 30th anniversary.
During ASTRO 2010, Nucletron highlighted improvements in its new Oncentra 4.0 treatment planning software and Flexitron afterloader.
The latest version of Oncentra improves external beam therapy planning and has GPU planning to speed dose calculations.
July 21, 2010 – A new version of a multimodality treatment planning system for brachytherapy and external beam treatment offers several features to increase planning speed and improve plan accuracy. Nucletron announced the upcoming release of Oncentra v4.0 at the American Association of Physicists in Medicine annual meeting this week.
November 1, 2009 - Nucletron offers the new Oncentra VMAT treatment planning solution for rotational therapy.
Nucletron will show the AccuBoost system with the microSelectron high-dose rate (HDR) brachytherapy afterloader treatment delivery solution for the treatment of breast cancer. The partnership will enable clinicians to deliver boost brachytherapy as part of the whole breast irradiation procedure.
November 20, 2008 - Nucletron, a knowledge-based leader in radiation oncology, has received 510(k) clearance from the FDA on Oncentra RT Viewer, its latest innovation in the Oncentra family of treatment planning solutions.
November 13, 2008 – Oncentra Brachy by Nucletron received regulatory clearance from Health Canada for its volume-based treatment planning solution designed to optimize cancer treatment planning with brachytherapy.
September 18, 2008 – Nucletron has created a strategic partnership with BrachySolutions to jointly expand the adoption ...